v3.26.1
Common Stock (Tables)
3 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Aggregate Warrants As of March 31, 2026, the following aggregate warrants to purchase shares of the Company’s common stock were issued and outstanding:

 

Issue Date

 

Expiration Date

 

Exercise Price per Share

 

 

Number of Shares subject to Outstanding Warrants

 

July 11, 2024

 

None

 

$

0.0001

 

 

 

285,715

 

October 27, 2023

 

None

 

$

0.0001

 

 

 

319,150

 

April 27, 2023

 

None

 

$

0.0001

 

 

270,270(1)

 

(1) In September 2024, 1,750,000 shares of common stock subject to outstanding pre-funded warrants were

cashless exercised and 1,749,993 shares of common stock were issued.

Schedule of Number of Common Stock Reserved for Future Issuance

The Company had reserved common stock for future issuance as follows:

 

 

 

March 31,

 

December 31,

 

 

2026

 

2025

Exercise of outstanding options under the 2015, 2019 and 2023 Plans

 

14,825,324

 

11,130,405

Shares available for grant under the 2019 Plan

 

3,007,833

 

2,833,979

Shares available for grant under the 2023 Inducement Plan

 

1,100,263

 

1,516,767

Shares available under the Employee Stock Purchase Plan

 

3,565,724

 

2,687,759

Pre-funded warrants issued and outstanding

 

875,135

 

875,135

Total

 

23,374,279

 

19,044,045